IldefonsoIsmaelRodriguez RiveraMD
Oncology • San Antonio, TXHematologic Oncology
Clinical Investigator, NEXT Oncology / Texas Oncology
Dr. Rodriguez Rivera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2829 Babcock Road
Ste. 300
San Antonio, TX 78229Phone+1 210-580-9500Fax+1 210-568-4397- Is this information wrong?
Summary
- Dr. Ildefonso Rodriguez Rivera is a Phase 1 clinical investigator, hematologist and medical oncologist in San Antonio, TX and is affiliated with multiple hospitals in the area. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 6 years. He also speaks multiple languages, including Spanish. He specializes in Phase 1 clinical trials and hematologic malignancies.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2015 - 2018
University of Texas at Austin Dell Medical SchoolResidency, Internal Medicine, 2014 - 2015
University of Texas M D Anderson Cancer CenterResidency, Research, 2013 - 2014
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Texas Southwestern Medical SchoolClass of 2011
Certifications & Licensure
NY State Medical License 2015 - 2026
TX State Medical License 2014 - 2024
NC State Medical License 2020 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Fellow Weill Cornell Medicine / Division of Hematology and Medical Oncology, 2017-2018
- Betty Lee Neuwirth Foundation Fellow in Oncology 2017
Clinical Trials
- A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma Start of enrollment: 2017 Dec 28
- A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2019 Apr 03
- A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2020 Feb 07
Publications & Presentations
PubMed
- 1 citationsClinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.Fushen Sha, Michelle Okwali, Anna Alperovich, Philip C Caron, Lorenzo Falchi, Audrey Hamilton, Paul A Hamlin, Steven M Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar,...> ;Blood Cancer Journal. 2022 Feb 10
- 69 citationsPhase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Samia Sohail, Alayna Santa...> ;Journal of Clinical Oncology. 2021 Jun 25
- 58 citationsOutcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.David Sermer, Connie L Batlevi, M. Lia Palomba, Gunjan L. Shah, Richard J. Lin, Miguel-Angel Perales, Michael Scordo, Parastoo B. Dahi, Martina Pennisi, Aishat Afuye, ...> ;Blood Advances. 2020 Oct 13
- Join now to see all
Abstracts/Posters
- Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin LymphomaIldefonso Rodriguez-Rivera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Ildefonso Rodriguez-Rivera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
Other Languages
- Spanish
External Links
- Texas Oncologyhttps://www.texasoncology.com/oncologist/ildefonso-rodriguez-rivera
- Next Oncology https://nextoncology.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
